The Science Advisory Board

President Biden launches $50M initiative to improve cancer outcomes in low-income areas

The Biden-Harris administration on Monday awarded $50 million to launch the Persistent Poverty Initiativ...

3D cellular models identify potential drug target for preventing Alzheimer’s

A 3D cellular model has shown that mutations affec...

Gene mutations linked to drug-resistant liver cancer

Certain gene mutations could serve as markers to hel...

Potential treatment for rare autoimmune disorder adapted from CAR-T therapy in study

Evidence from a small-scale clinical trial suggest...

FDA approves first gene therapy for treatment of certain patients with Duchenne muscular dystrophy

The U.S. Food and Drug Administration (FDA) on Thursda...

Cancer & Disease Research

Fatty liver in males linked to survival from infection
October 24, 2022 -- University of California, San Francisco scientists have investigated a sex-differentiated evolutionary pathway that regulates lipids, storing fat in the liver in males while releasing it into the bloodstream in females. Their research has relevance for 25% of Americans affected by fatty liver disease. Read More

NCI awards researchers $2M grant to reverse drug resistance in lung cancer
October 21, 2022 -- University of Missouri researchers were awarded a $2.35 million grant from the National Cancer Institute (NCI) to help overcome drug resistance in non-small cell lung cancer. Read More

Cell Biology

Precision BioSciences presents preclinical data for gene editing therapies
May 17, 2022 -- Precision BioSciences is scheduled to display preclinical data for its Arcus-based gene editing studies at the American Society of Gene & Cell Therapy’s annual meeting in Washington, DC. The showcase will include two oral presentations and two posters highlighting gene editing study results. Read More

Lunaphore and Indica Labs combine spatial biology and pathology imaging platforms
May 13, 2022 -- Lunaphore and Indica Labs have partnered on the development of a biological research tool involving software from both companies. This new solution will involve a combination of Lunaphore’s Comet spatial biology platform and Indica Labs’ Halo digital pathology image analysis software. Read More

Genomics

Avantor and Cytovance enter into plasmid manufacturing agreement
May 11, 2022 -- Avantor and Cytovance Biologics have entered into an agreement to advance the manufacturing of plasmids. This agreement will combine Avantor’s expertise in providing cell and gene therapy materials with Cytovance’s plasmid DNA manufacturing capabilities. Read More

Thermo Fisher releases new qPCR solutions to improve biologics development
May 11, 2022 -- Thermo Fisher Scientific has launched a series of QualTrak quantitative polymerase chain reaction (qPCR) biopharma solutions to enhance the drug development process for biologics. The qPCR offerings include QuantStudio 6 and 7 Pro real-time PCR systems and TaqMan and TaqPath master mixes and assays. These innovations support biopharma companies developing these novel therapeutics over the course of the lifespan of the biologics. Read More